Baduanjin Intervention in Clinical Studies After Coronary Revascularization Surgery
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorLiu Qiang
About this trial
1. To evaluate the efficacy and safety of the Baduanjin exercise programme in patients following coronary revascularisation surgery; 2. To develop a traditional Chinese medicine (TCM) rehabilitation protocol and evaluation system for patients following coronary revascularisation surgery; 3. To clarify the advantages of TCM rehabilitation in the post-operative management of coronary revascularisation surgery and to provide high-level evidence-based medical evidence for TCM rehabilitation protocols.
Eligibility criteria
Qualifiers
Participants who meet the diagnostic criteria for coronary heart disease
Participants who underwent successful percutaneous coronary intervention
Participants aged between 18 and 80
Participants of any gender
Disqualifiers
Subjects with severe hepatic or renal impairment
subjects with severe electrolyte disturbances
subjects with severe haematological disorders or malignant tumours
pregnant or breastfeeding women
Trial design
Treatments tested in this trial
- Standardized Western medical treatment + Standardized Baduanjin rehabilitation training
- Standardized Western medical treatment + Aerobic exercise training
Treatment groups
310 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Liu Qiang
Lead sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University
Sponsor institution
The Third Affiliated hospital of Zhejiang Chinese Medical University
Collaborator
Zhejiang Provincial People's Hospital
Collaborator
The First Affiliated Hospital of Zhejiang Chinese Medical University
Collaborator
Source ClinicalTrials.gov